Evidence map›Paper›PMID 39424929›Full record

ArticleMolecular psychiatry2025

Aging-dependent loss of functional connectivity in a mouse model of Alzheimer's disease and reversal by mGluR5 modulator.

Francesca Mandino, Xilin Shen, Gabriel Desrosiers-Grégoire, David O'Connor, Bandhan Mukherjee, Ashley Owens, An Qu, John Onofrey, Xenophon Papademetris, M Mallar Chakravarty and 2 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Correspondence of large-scale functional brain network decline across aging mice and humans.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Biphasic acclimation for simultaneous wide-field fluorescent CaImaging neuroscience (Cambridge, Mass.) · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Francesca MandinoDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06520, USA.ORCID 0000-0002-5605-0854
Xilin ShenDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06520, USA.
Gabriel Desrosiers-GrégoireComputational Brain Anatomy Laboratory, Cerebral Imaging Center, Douglas Mental Health University Institute, Montreal, QC, H4H 1R3, Canada.ORCID 0000-0003-2197-1183
David O'ConnorDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.ORCID 0000-0002-8885-518X
Bandhan MukherjeeCellular Neuroscience, Neurodegeneration and Repair Program, Yale School of Medicine, New Haven, CT, 06520, USA.
Ashley OwensCellular Neuroscience, Neurodegeneration and Repair Program, Yale School of Medicine, New Haven, CT, 06520, USA.
An QuDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06520, USA.
John OnofreyDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06520, USA.
Xenophon PapademetrisDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06520, USA.
M Mallar ChakravartyComputational Brain Anatomy Laboratory, Cerebral Imaging Center, Douglas Mental Health University Institute, Montreal, QC, H4H 1R3, Canada.ORCID 0000-0002-0759-5508
Stephen M Strittmatter *Cellular Neuroscience, Neurodegeneration and Repair Program, Yale School of Medicine, New Haven, CT, 06520, USA. stephen.strittmatter@yale.edu.ORCID 0000-0001-8188-3092
Evelyn M R Lake *Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06520, USA. evelyn.lake@yale.edu.ORCID 0000-0001-8255-8013

Funding

Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2020 to 2026
$30.2M
Prion Protein in Alzheimer's Disease PathophysiologyR01AG034924 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2010 to 2026
$9.6M
Multimodal imaging of prodromal synaptic, circuit, and network-level dysfunction in a murine model of Alzheimer's diseaseRF1NS130069 · NINDS · YALE UNIVERSITY · PI CAI, ZHENGXIN, LAKE, EVELYN MR · 2022 to 2022
$2.5M
Synaptic selectivity for microglial-mediated damage in Alzheimer's DiseaseRF1AG070926 · NIA · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2021 to 2021
$2.4M
Synaptic selectivity for microglial-mediated damage in Alzheimer's DiseaseR01AG070926 · NIA · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2024 to 2025
$1.6M
Leveraging simultaneous BOLD-fMRI and wide-field Ca2+ imaging to reveal measures of neurovascular health that cross scales and species which have AD symptom and treatment response prognostic utilityR21AG075778 · NIA · YALE UNIVERSITY · PI LAKE, EVELYN MR · 2022 to 2022
$461k
NIA NIH HHS P30 AG066508NIA NIH HHS R01 AG034924NIA NIH HHS R21 AG075778NIA NIH HHS RF1 AG070926NINDS NIH HHS RF1 NS130069
6 · The paper itself

Abstract

Amyloid accumulation in Alzheimer's disease (AD) is associated with synaptic damage and altered connectivity in brain networks. While measures of amyloid accumulation and biochemical changes in mouse models have utility for translational studies of certain therapeutics, preclinical analysis of altered brain connectivity using clinically relevant fMRI measures has not been well developed for agents intended to improve neural networks. Here, we conduct a longitudinal study in a double knock-in mouse model for AD (App

Indexed as

AgingAlzheimer DiseaseReceptor, Metabotropic Glutamate 5Amyloid beta-PeptidesAnimalsBrainDisease Models, AnimalFemaleGene Knock-In TechniquesLongitudinal StudiesMagnetic Resonance ImagingMaleMiceMice, Inbred C57BLMice, TransgenicAmyloid beta-PeptidesGrm5 protein, mouseReceptor, Metabotropic Glutamate 5

Identifiers

PMID39424929
PMCPMC12015114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.